Inventor
VAN RIETSCHOTEN KATERINE
GB15 patents
⚠️ This page may combine multiple inventors who share the name “VAN RIETSCHOTEN KATERINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BICYCLETX LTD
13 patentsUS11912792B2Feb 27, 2024
Bicyclic peptide ligands specific for nectin-4
BICYCLETX LTD14 citations93
US11833211B2Dec 5, 2023
Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2
BICYCLETX LTD15 citations93
US11696956B2Jul 11, 2023
Bicyclic peptide ligands specific for EphA2
BICYCLETX LTD18 citations93
US11484602B2Nov 1, 2022
Bicyclic peptide ligands specific for EphA2
BICYCLETX LTD16 citations93
US11453702B2Sep 27, 2022
Bicyclic peptide ligands specific for Nectin-4
BICYCLETX LTD16 citations93
US11180531B2Nov 23, 2021
Bicyclic peptide ligands specific for Nectin-4
BICYCLETX LTD18 citations93
US10857196B2Dec 8, 2020
Bicyclic peptide ligands and uses thereof
BICYCLETX LTD20 citations93
US10919937B2Feb 16, 2021
Bicyclic peptide ligands and uses thereof
BICYCLETX LTD29 citations92
US11241473B2Feb 8, 2022
Bicyclic peptide ligands and uses thereof
BICYCLETX LTD16 citations84
US11396530B2Jul 26, 2022
Bicyclic peptide ligands and uses thereof
BICYCLETX LTD16 citations83
US12459974B2Nov 4, 2025
Bicyclic peptide ligands specific for Nectin-4
BICYCLETX LTD0 citations57
US12492224B2Dec 9, 2025
Bicyclic peptide ligands specific for PD-L1
BICYCLETX LTD0 citations51
US11970555B2Apr 30, 2024
Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)
BICYCLETX LTD0 citations42